SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-23-000162
Filing Date
2023-03-13
Accepted
2023-03-13 07:53:31
Documents
14
Period of Report
2023-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT nhwk_8k.htm   iXBRL 8-K 32800
2 AMENDMENT NO. 5 TO RIGHTS AGREEMENT nhwk_ex4z6.htm EX-4.6 13199
  Complete submission text file 0001553350-23-000162.txt   266506

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nhwk-20230311.xsd EX-101.SCH 3739
4 XBRL DEFINITION FILE nhwk-20230311_def.xml EX-101.DEF 26569
5 XBRL LABEL FILE nhwk-20230311_lab.xml EX-101.LAB 36527
6 XBRL PRESENTATION FILE nhwk-20230311_pre.xml EX-101.PRE 25193
8 EXTRACTED XBRL INSTANCE DOCUMENT nhwk_8k_htm.xml XML 5277
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 23725732
SIC: 2834 Pharmaceutical Preparations